Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Neurosteroids help control dopamine responses in the brain.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Muscles can make their own androgens, which may help muscle growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

SARMs work differently in tissues due to unique interactions and structures.

Taurine may help reduce hair loss by improving hair growth cycles.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

New treatments for androgenetic alopecia show promise but need more research for validation.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New treatments for male hypogonadism are effective and should be personalized.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.